NCT06562140|UnknownDMC
Multidimensional Examination of Patients with Colorectal and Anal Cancer
MECACP
Loading search results
MECACP
Sponsor study identifier
observational
300
1 country
2
Study Start
August 15, 2024
Actual (reported)Primary Completion
September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The aim of our cross-sectional research is to assess changes in physical activity, functional capacity, and health status in individuals with colorectal and anal carcinoma using subjective measurement tools, with particular focus on those suffering from incontinence, through a cross-sectional study. Additionally, the research involves the Hungarian adaptation and validation of the quality of life questionnaire for colorectal cancer (EORTC QLQ-CR29), quality of life questionnaire for anal cancer (EORTC QLQ-AN27), and Fecal Incontinence Severity Index (FISI)" questionnaires.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 15, 2024
Actual (reported)August 16, 2024
Actual (reported)August 20, 2024
Actual (reported)September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Quality of life questionnaire for cancer patients - EORTC QLQ-C30
The EORTC QLQ-C30 questionnaire examines the general impact of cancer and its treatment. The minimum value is 30, maximum 120, where higher scores means worse health-related quality of life.
Baseline
Quality of life questionnaire for colorectal cancer - EORTC QLQ-CR29
The EORTC QLQ-CR29 questionnaire assesses the general impact of cancer and its treatment among colorectal cancer patients. The minimum value is 29, maximum 116, where higher scores means worse health-related quality of life
Baseline
Quality of life questionnaire for anal cancer - EORTC QLQ-AN27
The EORTC QLQ-CR29 questionnaire assesses the general impact of cancer and its treatment among anal cancer patients. The minimum value is 27, maximum 108, where higher scores means worse health-related quality of life
Patients aged 18 to 80 years with a diagnosis of colorectal carcinoma
Patients aged 18 to 80 years with a diagnosis of anal carcinoma
No intervention - cross-sectional observational study
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The study population is colorectal or anal cancer patients older than 18 years. Neuromuscular diseases, severe congenital musculoskeletal and other disorders, severe psychiatric illness, lack of cooperation, undergone other surgical procedures within the past year.
University of Pécs
Pécs, Baranya, 7621, Hungary
University of Pécs
Pécs, Hungary
First Submitted
August 16, 2024
First Posted
August 20, 2024
Study Start
August 15, 2024
Actual (reported)Primary Completion
September 1, 2025
Estimated (date passed)RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
Baseline
Global Physical Activity Questionnaire (GPAQ)
To measure physical activity patterns related to work, active transportation, leisure time activities and sitting time. The work time physical activity, active transportation, recreational activities and sitting time will be summarized as weekly minutes.
1 week
FECAL INCONTINENCE SEVERITY INDEX (FISI)
The questionnaire measures the frequency of the different incontinence events and the type of stool involved. The index provides a numerical score that reflects the overall severity of a patient's fecal incontinence. A total score is the sum of all points between 0 to 61, where the higher the score means more severe fecal incontinence.
Baseline
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
September 1, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
January 23, 2025
Record last verified: 2024-08
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: